FDA approves Novartis’ new dual combination bronchodilator Utibron Neohaler to treat COPD
Utibron Neohaler (indacaterol/glycopyrrolate), which is expected to be available in the first quarter of next year, can be used for the long-term maintenance treatment of airflow obstruction in